Physician profile
John Calvin Both
NPI 1760489322
$1,422.56
in general payments reported to CMS, 2019-2025
20 companies · $365 in 2025
The $365 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $538 · 2020: $190 · 2021: $181 · 2024: $149 · 2025: $365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $514.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $513.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $228.70 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $177.15 | 2019 | |
| Medtronic, INC. | $149.12 | 2024 | Osteocool Rf Ablation System |
| Boston Scientific Corporation | $137.84 | 2025 | Watchman Access System |
| Abbvie INC. | $135.17 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $125.10 | 2019-2025 | Airsupra, Farxiga |
| Amarin Pharma, INC. | $79.06 | 2019-2021 | |
| Vanda Pharmaceuticals INC. | $72.05 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $58.12 | 2019-2020 | |
| Novo Nordisk INC | $51.48 | 2019 | |
| Janssen Pharmaceuticals, INC | $41.86 | 2020-2021 | |
| Exact Sciences Corporation | $34.22 | 2025 | Cologuard Collection Kit |
| Sunovion Pharmaceuticals INC. | $31.20 | 2020-2021 | |
| Allergan, INC. | $23.65 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $18.49 | 2025 | Rexulti |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $14.30 | 2020 | |
| Amgen INC. | $11.39 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.39 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $11.33 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $10.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Both listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.